http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102860988-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56d4164e2c4f9b9b4d73cd8033675c0a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b07adac0c745030673d16c311969aec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9787da55efd43c770d22f7c60caba6d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ca6e699210f19ea71470b1eeb93178f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1455d969d3a44c2d426482e69fdd84f1 |
| publicationDate | 2013-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102860988-B |
| titleOfInvention | Chymotrypsin composition freeze-dried powder and preparation method thereof |
| abstract | The invention relates to a chymotrypsin preparation, particularly relates to chymotrypsin composition freeze-dried powder and a preparation method thereof. The hymotrypsin composition freeze-dried powder comprises chymotrypsin, dextran 20 and sorbitol, wherein the ratio of chymotrypsin to dextran 20 to sorbitol is 1 million units: 1-1.8g: 0.05-0.6g. The average porosity of the hymotrypsin composition freeze-dried powder is 85-98%. The invention further relates to a preparation method of the hymotrypsin composition freeze-dried powder. The hymotrypsin composition freeze-dried powder disclosed herein has the advantages of full and uniform appearance, high porosity, good re-solubility, high stability, simple prescription, low proportion of pharmaceutic adjuvants, low side effect to human body, safety and reliability. According to the invention, the preparation technology of the hymotrypsin composition freeze-dried powder is further improved, the temperature, liquid volume, and freeze-drying process are improved, and sterilization is conducted twice. |
| priorityDate | 2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.